Gastroenterologist and obesity medicine specialist Dr. Christopher McGowan performed the 5,000th endobariatric weight loss procedure this week at True You Weight Loss, marking the practice as the first in the nation to achieve this notable milestone. Endobariatrics: A New Approach…
Aditxt, Inc. (NASDAQ: ADTX), an innovation platform aimed at accelerating health advancements, has announced that its majority-owned subsidiary, Pearsanta, Inc., has entered into a Market Development Collaboration Agreement with Evofem Biosciences, a leader in women’s health. This partnership will focus…
Debiopharm Honors Recipients of 2024 JCA-Mauvernay Award for Breakthrough Cancer Research Debiopharm, a Swiss-based biopharmaceutical company focused on advancing cancer and infectious disease treatments, has announced the winners of the 2024 JCA-Mauvernay Award, celebrating its 20th edition. The award recognizes…
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leader in insulin delivery and diabetes technology, has announced that its t:slim X2 insulin pump, equipped with Control-IQ automated insulin delivery technology, is now approved for use with Eli Lilly’s Lyumjev® (insulin lispro-aabc…
AngioDynamics, Inc. (NASDAQ: ANGO), a leading medical technology company dedicated to enhancing vascular health and expanding cancer treatment options, has announced the launch of the RECOVER-AV trial. This prospective, multicenter, multinational, single-arm study will evaluate the efficacy, safety, and long-term…
Topline Results from TROPION-Breast01 Phase 3 Trial of Datopotamab Deruxtecan The TROPION-Breast01 phase 3 trial evaluating datopotamab deruxtecan (Dato-DXd) against investigator’s choice chemotherapy has reported that while the treatment met its primary endpoint for progression-free survival (PFS), it did not…
Genentech, part of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced positive topline results from the Phase III CENTERSTONE study of Xofluza® (baloxavir marboxil). The study showed that a single oral dose of Xofluza significantly reduced the transmission of…
Prolucent®, a top provider of healthcare workforce optimization solutions, is excited to announce two key new hires to boost market expansion and sales growth. Jason Phibbs has been appointed Vice President of Growth, and Darryl Green will take on the…
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company specializing in cancer and autoimmune disease treatments, has received approval to conduct a clinical trial for its BCL2 inhibitor, ICP-248, in combination with azacitidine for acute myeloid leukemia (AML) in…
Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company specializing in bioelectronic medicine, announced it has received Institutional Review Board (IRB) approval from The Feinstein Institutes for the next phase of clinical work on its non-invasive cervical vagus nerve…
Aura, a leader in personalized healthcare, has launched a groundbreaking at-home health check in New York. In just one hour, nurses conduct extensive blood work, imaging, cognitive assessments, and more, all from the comfort of your home. This holistic approach…
Alzprotect, a French biopharma company, has successfully completed the open-label extension (OLE) phase of its Phase 2a trial for AZP2006 (ezeprogind®) in treating Progressive Supranuclear Palsy (PSP). Results from the 6-month extension highlight AZP2006’s potential to stabilize or slow disease…